Steroids in treatment of giant cell arteritis
Are steroids still the mainstay treatment for giant cell arteritis? Are there perspectives for new therapies with fewer adverse effects?
Are steroids still the mainstay treatment for giant cell arteritis? Are there perspectives for new therapies with fewer adverse effects?
Which study is superior in the diagnostics of patients with giant cell arteritis: ultrasound or temporal artery biopsy?
How should we assess response to treatment in patients with ANCA-associated vasculitis?
Can clinicians use the Chapel Hill Consensus Conference definitions, European Medicines Agency (EMA) algorithm, or American College of Rheumatology (ACR) classification criteria in the diagnostic workup of patients with vasculitis?
Diagnosis of ANCA-associated vasculitis seems to be much easier with ANCA testing being widely available. Can we confirm or exclude ANCA-associated vasculitis based on the ANCA test result?